The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term taxane exposure and transdifferentiation of prostate cancer in vitro.
 
Gunhild Von Amsberg
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; Pfizer; Roche Pharma AG
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; MSD Oncology; Pfizer; Roche
Research Funding - AvenCell (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Lilly (Inst); MSD Oncology (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen Oncology; Pfizer/EMD Serono; Roche
 
Sergey Dyshlovoy
No Relationships to Disclose
 
Jessica Hauschild
No Relationships to Disclose
 
Verena Sailer
No Relationships to Disclose
 
Sven Perner
No Relationships to Disclose
 
Anne Offermann
No Relationships to Disclose
 
Lina Merkens
No Relationships to Disclose
 
Christoph Krisp
No Relationships to Disclose
 
Stefan Werner
No Relationships to Disclose
 
Klaus Pantel
No Relationships to Disclose
 
Moritz Kaune
No Relationships to Disclose
 
Derya Tilki
Honoraria - Advanced Accelerator Applications; Apogepha; AstraZeneca; Exact Sciences; Ipsen; Janssen; miR Scientific; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; miR Scientific; Roche
Research Funding - Janssen
 
Hartmut Schlüter
No Relationships to Disclose
 
Markus Graefen
Honoraria - Astellas Pharma; Bayer; Janssen; Medtronic; Takeda
Consulting or Advisory Role - Medtronic
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; Takeda
 
Carsten Bokemeyer
Honoraria - AstraZeneca; Bayer; Berlin-Chemie; Bristol-Myers Squibb; Medac; Merck KGaA; Merck Sharp Dohme; Roche; Sanofi
Consulting or Advisory Role - AOK Health Insurance; Bayer Schering Pharma; GSO; Janssen-Cilag GmbH; Merck Sharp & Dohme; Oncology Drug Consult (ODC); Sanofi
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Agile Therapeutics (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); Apellis Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BerGenBio (Inst); BioNTech (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); CPT Cellex Patient Treatment (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Glycostem (Inst); Glycotope GmbH (Inst); immatics (Inst); Incyte (Inst); IO Biotech (Inst); Ipsen (Inst); Isofol Medical (Inst); Janssen-Cilag (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Millennium (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier/Pfizer (Inst); Springworks Therapeutics (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; Merck Serono; Sanofi